Trials shows bimekizumab response durable at four years for moderate-to-severe psoriasis
by Tina BrownPatients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, according to research
Updated on: March 28,2024
0
Trials shows bimekizumab response durable at four years for moderate-to-severe psoriasis
by Tina BrownPatients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, according to research
Updated on:March 28,2024
0
